The Use of Immunosuppressive Therapy (IST) in Patients with the Myelodysplastic Syndromes (MDS): Clinical Outcomes and Their Predictors in a Large International Patient Cohort
Stahl, Maximilian, Deveaux, Michelle, de Witte, T. M. M, Neukirchen, Judith, Sekeres, Mikkael A., Brunner, Andrew M., Roboz, Gail J., Steensma, David P., Bhatt, Vijaya R., Platzbecker, Uwe, Cluzeau, Thomas, Prata, Pedro H, Fenaux, Pierre, Fathi, Amir T., Smith, Alex, Germing, Ulrich, Ritchie, Ellen K, Verma, Vivek, Podoltsev, Nikolai A., Arenillas, Leonor, Prebet, Thomas, Santini, Valeria, Gore, Steven D., Komrokji, Rami S., Zeidan, Amer M.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
The Impact of the Administration Schedule and Mutational Profile on Outcomes of Patients with Relapsed and Refractory Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Large, International, Multi-Center Analysis
Stahl, Maximilian, Deveaux, Michelle, Montesinos, Pau, Itzykson, Raphael, Ritchie, Ellen K, Sekeres, Mikkael A., Podoltsev, Nikolai A., Fathi, Amir T., Komrokji, Rami S., Bhatt, Vijaya R., Al-Kali, Aref, Cluzeau, Thomas, Santini, Valeria, Brunner, Andrew M., Roboz, Gail J., Fenaux, Pierre, Litzow, Mark R., Perreault, Sera, Kim, Tae Kon, Prebet, Thomas, Vey, Norbert, Verma, Vivek, Germing, Ulrich, Bergua, Juan, Serrano, Josefina, Gore, Steven D., Zeidan, Amer M.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Results from the U.S. Life after Stopping TKIs (LAST) Study
Atallah, Ehab, Schiffer, Charles A., Radich, Jerald P., Weinfurt, Kevin, Zhang, Mei-Jie, Kota, Vamsi, Pinilla-Ibarz, Javier, Moore, Joseph O., Larson, Richard A., Oehler, Vivian, Mauro, Michael J., Deininger, Michael W., Thompson, James E., Shah, Neil P., Wadleigh, Martha, Ritchie, Ellen K, Silver, Richard T, Cortes, Jorge E., Baim, Arielle, Horowitz, Mary M., Flynn, Kathryn
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Multivariate Efficacy Analysis of a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes
Uy, Geoffrey L., Lancet, Jeffrey E., Cortes, Jorge E., Newell, Laura F., Lin, Tara L., Ritchie, Ellen K, Stuart, Robert K., Strickland, Stephen A, Hogge, Donna, Solomon, Scott R, Stone, Richard M., Bixby, Dale L., Kolitz, Jonathan E., Schiller, Gary J., Wieduwilt, Matthew J., Shemanski, Lynn, Chiarella, Michael, Louie, Arthur C, Medeiros, Bruno C
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results
Gergis, Usama, Van Besien, Koen, Masson Frenet, Emeline, Shore, Tsiporah B., Mayer, Sebastian A., Phillips, Adrienne A., Hsu, Jingmei, Roboz, Gail J., Ritchie, Ellen K, Scandura, Joseph, Lee, Sangmin, Desai, Pinkal, Samuel, Michael, Ball, Jeffrey, Albano, Maria S., Ciubotariu, Rodica, Dobrila, Ludy, Romeo, Cynthia, Scaradavou, Andromachi
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Rates of Adverse Events per Patient-Year in a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes
Medeiros, Bruno C, Lancet, Jeffrey E., Cortes, Jorge E., Newell, Laura F., Lin, Tara L., Ritchie, Ellen K, Stuart, Robert K., Strickland, Stephen A., Hogge, Donna, Solomon, Scott R, Stone, Richard M., Bixby, Dale L., Kolitz, Jonathan E., Schiller, Gary J., Wieduwilt, Matthew J., Ryan, Robert J., Chiarella, Michael, Louie, Arthur C, Uy, Geoffrey L.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An Analysis from a Large International Patient Cohort
Stahl, Maximilian, Wei, Wei, Montesinos, Pau, Lengline, Etienne, Shallis, Rory M, Neukirchen, Judith, Bhatt, Vijaya R., Sekeres, Mikkael A., Fathi, Amir T., Konig, Heiko, Luger, Selina, Khan, Irum, Roboz, Gail J., Cluzeau, Thomas, Martínez-Cuadron, David, Raffoux, Emmanuel, Germing, Ulrich, Manikkam Umakanthan, Jayadev, Mukherjee, Sudipto, Brunner, Andrew M., Miller, Adam M., McMahon, Christine M., Ritchie, Ellen K., Rodríguez-Veiga, Rebeca, Itzykson, Raphael, Boluda, Blanca, Rabian, Florence, Tormo, Mar, Acuna Cruz, Evelyn Gloria, Rabinovich, Emma, Yoo, Brendan, Podoltsev, Nikolai A., Gore, Steven D., Zeidan, Amer M.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Characteristics, Treatment Patterns and Outcomes Among Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Who Present with Hyperleukocytosis: Findings from a Large International Patient Cohort
Stahl, Maximilian, Wei, Wei, Montesinos, Pau, Lengline, Etienne, Shallis, Rory M, Neukirchen, Judith, Bhatt, Vijaya R., Sekeres, Mikkael A., Fathi, Amir T., Konig, Heiko, Luger, Selina, Khan, Irum, Roboz, Gail J., Cluzeau, Thomas, Martínez-Cuadron, David, Raffoux, Emmanuel, Germing, Ulrich, Manikkam Umakanthan, Jayadev, Mukherjee, Sudipto, Brunner, Andrew M., Miller, Adam M., McMahon, Christine M., Ritchie, Ellen K., Rodríguez-Veiga, Rebeca, Itzykson, Raphael, Boluda, Blanca, Rabian, Florence, Tormo, Mar, Acuna Cruz, Evelyn Gloria, Rabinovich, Emma, Yoo, Brendan, Podoltsev, Nikolai A., Gore, Steven D., Zeidan, Amer M.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Phase I/II trial of glasdegib in patients with primary or secondary myelofibrosis
Gerds, Aaron Thomas, Tauchi, Tetsuzo, Ritchie, Ellen K., Deininger, Michael W.N., Jamieson, Catriona HM, Mesa, Ruben A., Heaney, Mark L., Komatsu, Norio, Minami, Hironobu, Su, Yun, Shaik, Mohammed Naveed, Zhang, Xiaoxi, DiRienzo, Christine, Zeremski, Mirjana, Woolfson, Adrian, Chan, Geoffrey, Talpaz, Moshe
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase II/III, multicenter, open-label, 3-arm study of gilteritinib, gilteritinib plus azacitidine, or azacitidine alone in the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia (AML) patients ineligible for intensive induction chemotherapy
Cortes, Jorge E., Altman, Jessica, Ritchie, Ellen K., Larson, Richard A., Claxton, David, Minden, Mark D., Goldenberg, Alec, Naoe, Tomoki, Yoon, Sung-Soo, Rousselot, Philippe H., Mueller-Tidow, Carsten, del Castillo, Teresa Bernal, Havelange, Violaine, Ciceri, Fabio, Knopinska-Posluszny, Wanda, Liu, Shufang, Shrivastava, Archita, James, Angela Joubert, Rich, Elizabeth Shima, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
An open-label, randomized phase III study of gilteritinib versus salvage chemotherapy in relapsed or refractory FLT3 mutation-positive acute myeloid leukemia
Perl, Alexander E., Cortes, Jorge E., Strickland, Stephen Anthony, Ritchie, Ellen K., Neubauer, Andreas, Martinelli, Giovanni, Naoe, Tomoki, Pigneux, Arnaud, Rousselot, Philippe H., Röllig, Christoph, Baer, Maria R., Larson, Richard A., James, Angela Joubert, Chen, Caroline, Shu, Lei, Hasabou, Nahla, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)— Transplant Outcomes Post HMA Therapy in a Large International Patient Cohort
Stahl, Maximilian, Deveaux, Michelle, Montesinos, Pau, Itzykson, Raphael, Ritchie, Ellen K, Sekeres, Mikkael A., Majhail, Navneet S., Podoltsev, Nikolai A., Fathi, Amir T., Komrokji, Rami S., Bhatt, Vijaya R., Al-Kali, Aref, Cluzeau, Thomas, Santini, Valeria, Brunner, Andrew M., Roboz, Gail J., Fenaux, Pierre, Litzow, Mark R., Perreault, Sera, Kim, Tae Kon, Prebet, Thomas, Vey, Norbert, Verma, Vivek, Kobbe, Guido, Bergua, Juan, Serrano, Josefina, Gore, Steven D., Zeidan, Amer M.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Single-Arm Phase II Trial of Pegylated Interferon Alpha 2a in Patients with High-Risk Essential Thrombocythemia or Polycythemia Vera Resistant or Intolerant to Hydroxyurea: MPN Symptom Impact & Quality of Life Results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 Global Phase II Trial
Dueck, Amylou C., Mascarenhas, John, Kosiorek, Heidi Elizabeth, Yacoub, Abdulraheem, Prchal, Josef T., Berenzon, Dmitriy, Baer, Maria R., Ritchie, Ellen K, Silver, Richard T, Kessler, Craig M., Winton, Elliott F., Finazzi, Maria Chiara, Rambaldi, Alessandro, Vannucchi, Alessandro M., Leibowitz, David S., Rondelli, Damiano, Arcasoy, Murat O., Catchatourian, Rosalind, Vadakara, Joseph, Rosti, Vittorio, Hexner, Elizabeth, Kremyanskaya, Marina, Orellana, Alicia, Sandy, Lonette, Tripodi, Joseph, Najfeld, Vesna, Salama, Mohamed E., Weinberg, Rona Singer, Rampal, Raajit K., Hoffman, Ronald, Mesa, Ruben A
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Validation of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) Score for Hypomethylating Agents (HMAs) Use in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)
Deveaux, Michelle, Stahl, Maximilian, Montesinos, Pau, Itzykson, Raphael, Ritchie, Ellen K, Sekeres, Mikkael A., Barnard, John, Podoltsev, Nikolai A., Brunner, Andrew M., Komrokji, Rami S., Bhatt, Vijaya R., Al-Kali, Aref, Cluzeau, Thomas, Santini, Valeria, Roboz, Gail J., Fenaux, Pierre, Litzow, Mark R., Fathi, Amir T., Perreault, Sera, Kim, Tae Kon, Prebet, Thomas, Vey, Norbert, Verma, Vivek, Germing, Ulrich, Bergua, Juan, Serrano, Josefina, Gore, Steven D., Zeidan, Amer M.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia Who Are Either Hydroxyurea-Resistant or Intolerant: Final Results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 Global Phase II Trial
Yacoub, Abdulraheem, Mascarenhas, John, Kosiorek, Heidi Elizabeth, Prchal, Josef T., Berenzon, Dmitriy, Baer, Maria R., Ritchie, Ellen K, Silver, Richard T, Kessler, Craig M., Winton, Elliott F., Finazzi, Maria Chiara, Rambaldi, Alessandro, Vannucchi, Alessandro M., Leibowitz, David S., Rondelli, Damiano, Arcasoy, Murat O., Catchatourian, Rosalind, Vadakara, Joseph, Rosti, Vittorio, Hexner, Elizabeth, Kremyanskaya, Marina, Orellana, Alicia, Sandy, Lonette, Tripodi, Joseph, Najfeld, Vesna, Salama, Mohamed E., Weinberg, Rona Singer, Rampal, Raajit K., Mesa, Ruben A, Goldberg, Judith D, Dueck, Amylou C., Hoffman, Ronald
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Impact of Peri-Transplant Molecular Mutations Onoutcomes of AML Patients Undergoing Fludarabine/ Melphalan Conditioned Allogeneic Stem Cell Transplant
Saldarriaga, Mateo Mejia, Tahri, Yassine, Lee, Sangmin, Chen, Zhengming, Shore, Tsiporah B., Guarneri, Danielle, Mayer, Sebastian, Phillips, Adrienne A, Gomez, Alexandra, Desai, Pinkal, Ritchie, Ellen K., Samuel, Michael B., Roboz, Gail J., van Besien, Koen, Hsu, Jingmei
Published in Transplantation and cellular therapy (01.03.2022)
Published in Transplantation and cellular therapy (01.03.2022)
Get full text
Journal Article
556 - Impact of Peri-Transplant Molecular Mutations Onoutcomes of AML Patients Undergoing Fludarabine/ Melphalan Conditioned Allogeneic Stem Cell Transplant
Saldarriaga, Mateo Mejia, Tahri, Yassine, Lee, Sangmin, Chen, Zhengming, Shore, Tsiporah B., Guarneri, Danielle, Mayer, Sebastian, Phillips, Adrienne A, Gomez, Alexandra, Desai, Pinkal, Ritchie, Ellen K., Samuel, Michael B., Roboz, Gail J., van Besien, Koen, Hsu, Jingmei
Published in Transplantation and cellular therapy (01.03.2022)
Published in Transplantation and cellular therapy (01.03.2022)
Get full text
Journal Article
MPN-038: Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis: A Phase 2 Study
Harrison, Claire, Garcia, Jacqueline S., Mesa, Ruben, Somervaille, Tim, Ritchie, Ellen K., Komrokji, Rami S., Pemmaraju, Naveen, Jamieson, Catriona, Papadantonakis, Nikolaos, Foran, James M., O'Connell, Casey L., Verstovsek, Srdan, Jung, Paul, Holes, Leanne, Masud, Abdullah, Harb, Jason, Hutti, Jessica E., Prchal, Josef T.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Get full text
Journal Article
Comprehensive Geriatric Assessment Does Not Predict Overall Survival in Older Patients with Acute Myeloid Leukemia (AML)
Ritchie, Ellen K., Marshall, Danielle C., Greenberg, Molly D., Curcio, Tania J., Giambrone, Ashley E., Christos, Paul, Feldman, Eric J., Scandura, Joseph M., Roboz, Gail J.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Interleukin 2 Receptor-α (CD25) Expression Is Associated with Shortened Overall Survival and Resistance to Induction Therapy with Plerixafor and Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
Allan, John N., Roboz, Gail J., Feldman, Eric J., Scandura, Joseph M., Ritchie, Ellen K., Lam, Linda, Xie, Wen, Hsu, Hsiao-Ting, Hassane, Duane C, Guzman, Monica L.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article